Baxalta Incorporated When Issued News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.08.18	Shire Announces Tender Offers For Up To $2.25 Bln Principal Amount Of Notes (RTTNews)
06.10.16	Kamada To Produce GLASSIA For Shire Through 2020 - Quick Facts (RTTNews)
03.06.16	Shire Completes Combination With Baxalta - Quick Facts (RTTNews)
27.05.16	Baxalta Announces Shareholder Approval For Merger Deal With Shire - Quick Facts (RTTNews)
28.04.16	Baxalta Q1 Profit Down On Charges, Revenues Up - Quick Facts (RTTNews)
28.04.16	Baxalta Inc. Q1 Income Climbs 18% (RTTNews)
07.04.16	Shire Says Proposed Merger With Baxalta On Track To Close In Mid-2016 (RTTNews)
04.04.16	Baxalta :ADYNOVATE Approved To Treat 12 Years & Older With Hemophilia A In Japan (RTTNews)
04.03.16	Baxalta Commences Phase 1 Clinical Trial Of BAX 826 - Quick Facts (RTTNews)
02.03.16	Baxalta Submits MAA To European Medicines Agency For Adynovi- Quick Facts (RTTNews)
26.02.16	SGYP On Watchlist, BXLT Seeks New Use For Hemophilia Drug, ZTS Gets FDA Nod (RTTNews)
16.02.16	Baxalta To Not Host Investor Conference And Update 2016 Guidance - Quick Facts (RTTNews)
16.02.16	Baxalta Inc. Q4 Profit Retreats 18% (RTTNews)
11.01.16	Shire To Combine With Baxalta In $32 Bln Cash And Stock Deal (RTTNews)
11.01.16	Coherus: Second Pivotal Study On CHS-0214 Meets Primary Endpoint - Quick Facts (RTTNews)
04.01.16	Baxalta And Symphogen Announce Broad Strategic Immuno-oncology Collaboration (RTTNews)
03.01.16	Shire In Advanced Talks To Buy Baxalta: Bloomberg (RTTNews)
21.12.15	Baxalta: Adynovate Meets Endpoints In Phase 3 Study Of Hemophilia A Patients (RTTNews)
09.12.15	FDA Oks First Recombinant Von Willebrand Factor To Treat Bleeding Episodes (RTTNews)
07.12.15	Baxalta Presents Additional Data On Newly-Approved ADYNOVATE (RTTNews)
30.11.15	Baxalta Announces U.S. Availability Of Adynovate - Quick Facts (RTTNews)
23.11.15	Baxalta Gets Positive CHMP Opinion For ONCASPAR - Quick Facts (RTTNews)
16.11.15	Baxalta : FDA Okays Modified Antihemophilic Factor For Hemophilia A (RTTNews)
29.10.15	Baxalta Raises Outlook For Second Half Of 2015 - Quick Facts (RTTNews)
29.10.15	Baxalta Inc. Q3 Income Declines 3% (RTTNews)
02.09.15	Baxalta Reportedly Abandons Takeover Talks With Ariad Pharma (RTTNews)
05.08.15	Baxalta Rejects Shire's Unsolicited $30 Bln Takover Bid (RTTNews)
04.08.15	Shire Offers To Acquire Baxalta For $45.23/share - Quick Facts (RTTNews)
30.07.15	EARNINGS SUMMARY: Details of Baxalta Inc. Q1 Earnings Report (RTTNews)
27.07.15	Baxalta: CHMP Adopts Positive Opinion On OBIZUR - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	255.50	0.75 %	K V
Nestle	74.88	0.62 %	K V
CieFinRichemont	137.90	0.40 %	K V
Swiss Life Hldg	699.60	0.32 %	K V
Swisscom	504.50	0.30 %	K V
Sika	215.80	-0.37 %	K V
Givaudan	3’966.00	-0.40 %	K V
Lonza Grp	535.80	-0.41 %	K V
Geberit	514.60	-0.46 %	K V
ABB	49.07	-0.95 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Baxalta Incorporated When Issued

Aktien Top/Flop

Baxalta Incorporated When Issued Peer Group Nachrichten

Meistgelesene Nachrichten